The amyloid rollercoaster continues as another big Alzheimer's trial fails
Gizmag Emerging Technology Magazine,
A new announcement from pharmaceutical company Roche has revealed the failure of a massive global Phase 3 trial testing its…
A new announcement from pharmaceutical company Roche has revealed the failure of a massive global Phase 3 trial testing its…
Biogen recently announced that it was abandoning its late stage drug for Alzheimer’s, aducanumab, causing investors to lose…
For decades, a single overriding hypothesis has guided the majority of research into Alzheimer's disease, but after a string of…
If you had been sitting in the main room of the 2015 Alzheimer's association international conference, you would have heard a…